Print

NeurogesX, Inc. (NGSX) Reports Third Quarter 2012 Results  
11/15/2012 7:49:31 AM

SAN MATEO, Calif., Nov. 14, 2012 (GLOBE NEWSWIRE) -- NeurogesX, Inc. (OTCQB:NGSX) (OTCBB:NGSX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies, today provided an update on recent developments and reported results for its third quarter ended September 30, 2012.
//-->